Zenrelia [4.8 mg, 6.4 mg, 8.5 mg, 15 mg] Tablets for Dogs containing ilunocitinib
The Australian Pesticides and Veterinary Medicines Authority (APVMA) has before it an application for the approval of a new active constituent, ilunocitinib, in conjunction with applications for the registration of a suite of new products, Zenrelia [4.8 mg, 6.4 mg, 8.5 mg, 15 mg] Tablets for Dogs, for the reduction of pruritus associated with allergic dermatitis and reduction of clinical signs of atopic dermatitis in dogs.